1.1)复旦大学附属肿瘤医院肿瘤研究所,复旦大学上海医学院肿瘤学系,上海 200032;2.2)国家肝癌科学中心,上海 201805;3.3)国际合作信号转导实验室,东方肝胆外科医院,第二军医大学,上海 2000438
Tel: 021-81888141
面上项目(81773075)和上海市科委国际合作项目(18410720600)资助
1.1)Department of Cancer Institute, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China;2.2)National Center for Liver Cancer, Shanghai 201805, China;3.3)The International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China
The National Natural Science Foundation of China
程序性细胞死亡对于机体的生长发育及组织器官的稳态具有重要作用。坏死性凋亡是最近发现的一种可调控的程序性细胞死亡方式,其在形态学上具有坏死的特征。目前的研究表明,坏死性凋亡是由Receptor-interacting serine/threonine-protein kinase 3 (RIPK3)以及其底物Mixed lineage kinase domain-like protein (MLKL) 共同介导。细胞的增殖和死亡在维持机体内环境稳态中发挥重要作用,大量研究表明坏死性凋亡的失调和人类疾病的发展密切相关,比如炎症性疾病,自身免疫性疾病,肿瘤以及退行性病变。在这篇综述中,我们将讨论坏死性凋亡的分子机制及其相关疾病的研究进展。
Programmed cell death is critical for maintenance cellular organisms homeostasis. Necroptosis is a recently identified mode of programmed cell death that morphologically similar to necrosis. Necroptosis is mediated by Receptor-interacting serine/threonine-protein kinase 3 (RIPK3) and its substrate Mixed lineage kinase domain-like protein(MLKL). It has been shown that necroptosis is related to several human diseases, such as inflammatory diseases, autoimmune diseases, tumors and degenerative diseases. In this review, we will discuss the molecular mechanisms of necroptosis and its associated diseases.
石珅男,覃夏,王红阳,蔡振宇.坏死性凋亡研究进展[J].生物化学与生物物理进展,2020,47(7):561-573
复制生物化学与生物物理进展 ® 2025 版权所有 ICP:京ICP备05023138号-1 京公网安备 11010502031771号